- Report Summary
- Table of Contents
- Enquiry Before Buying
Report Summary
The global neuromodulation devices market is expected to grow significantly from USD 5,120 Million in 2018 to USD 10,200 Million in 2025, at a CAGR of 10.3% from 2019 to 2025. Factors driving the market growth are; rising prevalence of neurological diseases across the globe, government initiative for product approvals and investments, and rising geriatric population across the globe. In addition, growing use in SCS technology, increasing awareness for neuromodulation, and new product launches are further boosting the industry growth.
Neuromodulation devices are advanced medical tools that improve nervous system activities. Research and development activities conducted over the past two decades show that neuromodulation is safe, effective and durable treatment for chronic pain. Furthermore, the market has witnessed technological advancements such as bluetooth technology to spinal cord stimulators which allow doctors and patients to modify the intensity level in real time. However, high capital investments may hamper the market growth to some extent.
Deep Brain Stimulation (DBS) Technology Drives the Market Demand
Deep brain stimulation technology segment is expected to grow at the fastest CAGR during 2019-2025. Deep brain stimulation is a neurosurgical procedure involving the placement of neurostimulator, which sends electrical impulse through implanted electrodes. DBS is an established treatment for people with movement disorders such as Parkinson’s disease, dystonia, essential tremor, and psychiatric conditions including obsessive-compulsive disorder. Moreover, large and small competitors have targeted DBS, which has the potential to address a number of highly prevalent and underserved diseases and disorders.
Neuromodulation Devices Market – Regional insight
North America held the major share of the global Neuromodulation Devices Market in 2018. The growth is attributed to the increasing prevalence of chronic pain, and several government initiatives for product approvals. Moreover, over the past few years technological advancements in medical device and innovative minimally invasive surgical techniques have shown promising growth in the region.
The United States is likely to offer lucrative opportunities
Demographically, the United States is projected to witness a considerable growth in the geriatric population that is a major end user for medical devices. According to the US Census Bureau, the number of adults aged 65 and above is likely to increase significantly by 2021. Besides the increasing number of elderly adults in the country, the average life expectancy has constantly risen over the past decade. Owing to the aforementioned factors, the market is likely to witness significant growth in the region.
RESEARCH METHODOLOGY
The research and analysis are based on data and information obtained from various primary and secondary sources. The data obtained is validated by interacting with the companies of the concerned domain. The steps involved in the research methodology are;
- Obtaining historical data of the market based on news, articles, publications, annual reports, white papers, surveys and other secondary sources
- Interacting with key opinion leaders of the market and developing data points based on interaction with them
- Study of past trends in the market and their year on year impact on the market size and share
- Analyzing the collected data points
- Bridging the data points to calculate the neuromodulation devicesmarket and its various segments
- Anticipating potential risks
- Analyzing market forces such as drivers, restraints, and opportunities to assess new growth areas for theneuromodulation devicesmarket
- Finalizing the overall size and share for the global neuromodulation devicesmarket
The years used for the assessment are as follows;
- Historical year : 2015, 2016 and 2017
- Base year : 2018
- Forecast period: 2019 – 2025
OBJECTIVES:
- To classify global neuromodulation devicesmarket into segments on the basis of material, product type, end-user and regionto analyze their growth prospects individually
- To analyze market trends, opportunities, drivers and restraints associated with neuromodulation devices
- Profiling key companies operating in the global neuromodulation devicesmarket
- To study market response with respect to the mergers and acquisitions in the industry
Table of Contents
TABLE OF CONTENTS
CHAPTER 1. Market Scope and Methodology
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List Of Data Sources
CHAPTER 2. Executive Summary
2.1. Global Neuromodulation Devices- Market Snapshot
CHAPTER 3. Industry Analysis
3.1. Market Definition
3.2. Market Segmentation
3.3. Key Findings of the Global Neuromodulation Devices Market
3.4. Value Chain Analysis
3.5. Market Opportunities
3.5.1. Advancements in neuromodulation technology
3.5.2. Key innovation drives new product launches
3.6. Market Trends
3.6.1. Rising prevalence of neurological diseases
3.6.2. Increasing adoption of minimally invasive surgery
3.7. Market Dynamics
3.7.1. Market driver analysis
3.7.1.1. Rising geriatric population across the globe
3.7.1.2. Growing use in SCS technology
3.7.1.3. Government initiative for product approvals and investments
3.7.2. Market Restraint Analysis
3.7.2.1. High capital investment
CHAPTER 4. Competitive Outlook
4.1. Company Market Share Analysis
4.2. Porters Five Forces Analysis
CHAPTER 5. Global Neuromodulation Devices Market Size and Forecast (2015 – 2025)
5.1. Global Neuromodulation Devices Market, By Technology (USD Million)
5.1.1. Internal Neuromodulation
5.1.1.1. Deep Brain Stimulation (DBS)
5.1.1.2. Sacral Nerve Stimulation (SNS)
5.1.1.3. Spinal Cord Stimulation (SCS)
5.1.1.4. Vagus Nerve Stimulation (VNS)
5.1.1.5. Gastric Electrical Stimulation (GES)
5.1.2. External Neuromodulation
5.1.2.1. Transcranial Magnetic Stimulation
5.1.2.2. Transcutaneous Electrical Nerve Stimulation
5.1.2.3. Respiratory Electrical Stimulation
5.2. Global Neuromodulation Devices Market, By Application (USD Million)
5.2.1. Pain Management
5.2.2. Parkinson’s
5.2.3. Urinary and Fecal Incontinence
5.2.4. Dystonia
5.2.5. Depression
5.2.6. Epilepsy
5.2.7. Others
5.3. Global Neuromodulation Devices Market, By End-user (USD Million)
5.3.1. Hospitals
5.3.2. Home Setting
5.3.3. Clinics
CHAPTER 6. Global Neuromodulation Devices Market, By Geography
6.1. North America Neuromodulation Devices Market
6.1.1. North America Neuromodulation Devices Market, By Technology (USD Million)
6.1.2. North America Neuromodulation Devices Market, By Application (USD Million)
6.1.3. North America Neuromodulation Devices Market, By End-User (USD Million)
6.1.4. North America Neuromodulation Devices Market, By Country
6.1.4.1. The United States
6.1.4.2. Canada
6.1.4.3. Mexico
6.2. Europe Neuromodulation Devices Market
6.2.1. Europe Neuromodulation Devices Market, By Technology (USD Million)
6.2.2. Europe Neuromodulation Devices Market, By Application (USD Million)
6.2.3. Europe Neuromodulation Devices Market, By End-User (USD Million)
6.2.4. Europe Neuromodulation Devices Market, By Country
6.2.4.1. Germany
6.2.4.2. Spain
6.2.4.3. France
6.2.4.4. U.K
6.2.4.5. Italy
6.2.4.6. Russia
6.2.4.7. Rest of Europe
6.3. Asia-Pacific Neuromodulation Devices Market
6.3.1. Asia-Pacific Neuromodulation Devices Market, By Technology (USD Million)
6.3.2. Asia-Pacific Neuromodulation Devices Market, By Application (USD Million)
6.3.3. Asia-Pacific Neuromodulation Devices Market, By End-User (USD Million)
6.3.4. Asia-Pacific Neuromodulation Devices Market, By Country
6.3.4.1. Japan
6.3.4.2. India
6.3.4.3. Australia
6.3.4.4. China
6.3.4.5. Rest of Asia-Pacific
6.4. Central & South America Neuromodulation Devices Market
6.4.1. Central & South America Neuromodulation Devices Market, By Technology (USD Million)
6.4.2. Central & South America Neuromodulation Devices Market, By Application (USD Million)
6.4.3. Central & South America Neuromodulation Devices Market, By End-User (USD Million)
6.4.4. Central & South America Neuromodulation Devices Market, By Country
6.4.4.1. Brazil
6.4.4.2. Argentina
6.4.4.3. Rest of Central & South America
6.5. Middle East and Africa Neuromodulation Devices Market
6.5.1. Middle East and Africa Neuromodulation Devices Market, By Technology (USD Million)
6.5.2. Middle East and Africa Neuromodulation Devices Market, By Application (USD Million)
6.5.3. Middle East and Africa Neuromodulation Devices Market, By End-User (USD Million)
6.5.4. Middle East and Africa Neuromodulation Devices Market, By Country
6.5.4.1. Saudi Arabia
6.5.4.2. South Africa
6.5.4.3. Rest of Middle East and Africa
CHAPTER 7. Key Players and Strategic Developments
7.1. Medtronic
7.1.1. Business Overview
7.1.2. Product and Service Offering
7.1.3. Financial Overview
7.1.4. Strategic Developments
7.2. NeuroPace, Inc.
7.2.1. Business Overview
7.2.2. Product and Service Offering
7.2.3. Financial Overview
7.2.4. Strategic Developments
7.3. Abbot
7.3.1. Business Overview
7.3.2. Product and Service Offering
7.3.3. Financial Overview
7.3.4. Strategic Developments
7.4. Boston Scientific Corporation
7.4.1. Business Overview
7.4.2. Product and Service Offering
7.4.3. Financial Overview
7.4.4. Strategic Developments
7.5. ALEVA NEUROTHERAPEUTICS SA
7.5.1. Business Overview
7.5.2. Product and Service Offering
7.5.3. Financial Overview
7.5.4. Strategic Developments
7.6. Stimwave LLC
7.6.1. Business Overview
7.6.2. Product and Service Offering
7.6.3. Financial Overview
7.6.4. Strategic Developments
7.7. Nevro Corp.
7.7.1. Business Overview
7.7.2. Product and Service Offering
7.7.3. Financial Overview
7.7.4. Strategic Developments
7.8. Integer Holdings Corporation
7.8.1. Business Overview
7.8.2. Product and Service Offering
7.8.3. Financial Overview
7.8.4. Strategic Developments
7.9. Bioness Inc.
7.9.1. Business Overview
7.9.2. Product and Service Offering
7.9.3. Financial Overview
7.9.4. Strategic Developments
7.10. LivaNova PLC
7.10.1. Business Overview
7.10.2. Product and Service Offering
7.10.3. Financial Overview
7.10.4. Strategic Developments
Enquiry Before Buying
Global Neuromodulation Devices Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation and Forecast 2025
Related Reports
-
Global Catheters Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2025
May 31, 2019 -
Global Left Atrial Appendage (LAA) Closure Devices Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2025
May 27, 2019 -
Global Infectious Disease Diagnostic Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2025
May 22, 2019 -
Global Smart Contact Lenses Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2025
May 18, 2019
The post Global Neuromodulation Devices Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2025 appeared first on Energias Market Research.
This post first appeared on Market Research Reports, Market Analysis, Market Survey, please read the originial post: here
